#160 - Paul Offit, M.D.: The latest on COVID-19 vaccines and their safety, herd immunity, and viral variants
Dr. Paul Offit, a pediatrician and vaccine expert on the FDA committee, updates on SARS-CoV-2 vaccines, addresses mRNA vaccine concerns, and discusses immunology, variants, herd immunity, and future pandemic preparedness. He emphasizes the importance of understanding immune responses and global collaboration.
Deep Dive Analysis
16 Topic Outline
Update on SARS-CoV-2 Vaccine Strategies and Technologies
Addressing Concerns About mRNA Vaccines and DNA Alteration
Long-Term Side Effects of Vaccines and Historical Precedents
Lessons from HIV Vaccine Failures and Viral Mutation
SARS-CoV-2 Mutation Spectrum: Between Flu and Measles
Short-Term vs. Long-Term Immune Response and Memory Cells
Importance of Second mRNA Vaccine Dose and Immunogen Power
Understanding Relative vs. Absolute Risk Reduction in Vaccines
Implications of Pausing the J&J Vaccine and Public Trust
Defining Herd Immunity for Mucosal Viruses and SARS-CoV-2
Vaccine Hesitancy and its Impact on Reaching Herd Immunity
Timeline for Achieving Herd Immunity and Future Vaccination Needs
Vaccinating Children: Vectors vs. Direct Harm (MIS-C)
Theories on the Origin of SARS-CoV-2: Natural vs. Lab Escape
Preparing for Future Pandemics: Lessons Learned and International Collaboration
The Greatest Failure of the Current Pandemic: Testing
8 Key Concepts
mRNA Vaccine Mechanism
Unlike traditional vaccines that introduce a viral protein, mRNA vaccines deliver the gene that codes for the viral protein (e.g., SARS-CoV-2 spike protein). The body's cells then translate this mRNA into the protein, which subsequently triggers an antibody response. The mRNA is translated in the cytoplasm over days and then breaks down, unable to alter DNA.
Long-Term Vaccine Side Effects
Historically, any serious adverse event associated with vaccines has been picked up within two months of administration. Examples like narcolepsy from a flu vaccine, polio from oral polio vaccine, or Guillain-Barre syndrome from influenza vaccine, all manifested within weeks or months, not years later.
HIV's Virulence Strategy
HIV is a particularly heinous virus because it constantly mutates its surface protein during a single infection, preventing the immune system from catching up. Additionally, it primarily reproduces in T helper cells, which are crucial orchestrators of the immune system, effectively paralyzing the body's ability to fight back.
Viral Mutation Spectrum
Viruses like influenza mutate rapidly (genetic drift), requiring yearly vaccines, while others like measles mutate in a confined way, allowing long-lasting vaccine efficacy. SARS-CoV-2 mutates more slowly than influenza but more than measles, falling into an intermediate category where variants emerge, but current vaccines still protect against severe disease.
Cellular Immune Response
Beyond immediate antibody responses, the cellular immune system involves memory B cells, memory T helper cells, and memory cytotoxic T cells. These long-lived memory cells can be activated upon re-exposure to differentiate into antibody-producing cells or cells that kill virus-infected cells, providing durable immunity even after antibody titers fade.
Absolute Risk Reduction (ARR)
ARR measures the actual difference in risk between a vaccinated group and a placebo group, expressed as a percentage. This contrasts with relative risk reduction (RRR), which can make vaccine efficacy appear more dramatic. For example, the J&J vaccine had a 1.7% ARR, while Moderna had 1.2% and Pfizer less than 1%, indicating all are highly effective but J&J offered a higher absolute benefit in its trial population.
Herd Immunity for Mucosal Viruses
For mucosal viruses like SARS-CoV-2 (and rotavirus), herd immunity aims to significantly slow the spread rather than eliminate the virus entirely. This requires a high percentage of the population (estimated at least 80% for SARS-CoV-2) to be immune through natural infection or vaccination to protect vulnerable individuals and reduce transmission.
Multi-System Inflammatory Syndrome in Children (MIS-C)
MIS-C is a severe inflammatory disease seen in children, often a month after an asymptomatic SARS-CoV-2 infection. It involves high fever and inflammation affecting multiple organs (heart, liver, lung, kidney) due to the immune system mounting an inflammatory response against the body's own cells, particularly those lining blood vessels.
9 Questions Answered
No, mRNA vaccines cannot alter human DNA. The mRNA cannot cross the nuclear membrane, is RNA not DNA, and lacks the necessary enzymes (reverse transcriptase, integrase) to convert to DNA or insert into the genome.
SARS-CoV-2 mutates more slowly than influenza, which requires yearly vaccine updates, but more frequently than measles, for which vaccines offer decades of protection. It falls into an intermediate category where variants emerge, but current vaccines still protect against severe critical disease.
The second dose of mRNA vaccines is crucial for stimulating T helper cells and cytotoxic T cells, which are vital for inducing longer-lived and more robust immune responses, including memory cells, and likely better protection against variants.
While the J&J vaccine had a rare risk of blood clots (approximately 1 per million doses), it is estimated to prevent about 1,850 deaths per million vaccinated. This suggests a significant net benefit in preventing severe outcomes.
To significantly slow the spread of SARS-CoV-2 and achieve herd immunity, at least 80% of the population likely needs to be immune, either through natural infection or vaccination.
If vaccination rates continue at over 3 million doses per day, the U.S. could vaccinate enough additional people to approach herd immunity levels by mid-summer. However, the true impact will be seen next winter, as it is primarily a winter respiratory virus.
Vaccinating children is important both because they can act as vectors for transmission and due to the risk of direct harm to children, particularly the severe multi-system inflammatory disease (MIS-C) which can have long-term health consequences.
The two main theories are that the virus naturally jumped from bats to humans, possibly via an intermediate mammal, originating in a wet market, or that it was an accidental escape from a lab near Wuhan where gain-of-function studies might have been conducted.
The greatest single failure was the inability to rapidly develop, produce, and distribute enough tests at the outset of the pandemic, despite having the virus's sequence by January 2020. This delayed containment efforts significantly.
19 Actionable Insights
1. Prepare for Next Pandemic with Global Collaboration
Establish an international collaboration for surveillance, sequencing, and resource sharing (PPE, ventilators, vaccines) to monitor and respond to future pandemics, ensuring all nations are prepared and supported.
2. Ensure Global Vaccine Equity
Economically and technologically advanced nations should prioritize providing billions of mRNA vaccine doses to all countries, even if it means restricting intellectual property, recognizing global interdependence in pandemic control.
3. Prioritize Second mRNA Vaccine Dose
Always get the second dose of mRNA vaccines to achieve more durable, complete, and effective immunity, especially against emerging variants, as a single dose provides less robust protection.
4. Understand mRNA Vaccine Safety & DNA
Reassure yourself and others that mRNA vaccines cannot alter your DNA because the mRNA lacks necessary signals and enzymes to enter the nucleus, convert to DNA, or insert into your genome.
5. Recognize Vaccine Side Effect Timelines
Understand that serious vaccine adverse events, if they occur, are almost always identified within two months of vaccination, based on historical vaccine data.
6. Interpret Vaccine Efficacy Beyond Relative Risk
When evaluating vaccine efficacy, focus on absolute risk reduction (ARR) rather than just relative risk reduction (RRR), as ARR provides a more accurate measure of individual benefit.
7. Weigh J&J Vaccine Risk vs. Benefit
Consider that even with rare clotting events, the J&J vaccine prevents significantly more deaths (e.g., ~2,000 deaths prevented per million doses vs. 1 clotting event), making the benefit-to-risk ratio highly favorable.
8. Understand Societal Vaccination Responsibility
Recognize that choosing not to get vaccinated for a contagious disease like COVID-19 potentially affects others by increasing transmission risk, which may justify societal decisions regarding privileges like travel or employment in vulnerable settings.
9. Vaccinate Children to Prevent MIS-C
Consider vaccinating children not only to reduce their role as vectors but also to protect them from severe outcomes like Multi-system Inflammatory Syndrome in Children (MIS-C), which can cause long-term organ damage.
10. Set Realistic Herd Immunity Expectations
Understand that for mucosal viruses like SARS-CoV-2, the goal is to significantly slow its spread, not eliminate it, likely requiring at least 80% population immunity from natural infection or vaccination.
11. Monitor Herd Immunity by Next Winter
Assess the success of herd immunity efforts by observing the severity of the next winter’s COVID-19 season; a significant surge would indicate insufficient population immunity.
12. Prepare for Lifelong COVID-19 Vaccination
Expect that ongoing vaccination efforts against SARS-CoV-2 will be necessary for years, potentially for a lifetime, to maintain population immunity as the virus is unlikely to disappear.
13. Understand Long-Term Vaccine Booster Needs
Anticipate that the frequency of COVID-19 vaccine boosters will become clearer in about two years, with current optimism suggesting protection for a few years rather than decades.
14. Address Vaccine Hesitancy Differently
Distinguish between vaccine skeptics, who can be convinced with data and logic, and vaccine cynics, who distrust institutions and may not be swayed by reason, requiring different communication approaches.
15. Improve Pandemic Testing Infrastructure
For future pandemics, ensure rapid deployment of diverse, quality-controlled testing by involving multiple groups beyond a single federal agency, learning from past failures in test availability and distribution.
16. Understand SARS-CoV-2 Incubation & Immunity
Recognize that SARS-CoV-2’s intermediate six-day incubation period means immunity aims to modify disease rather than achieve sterilizing immunity, making immunization or natural infection the primary choices for protection.
17. Appreciate Cellular Immune Memory
Understand that long-term protection against SARS-CoV-2 relies on immunological memory (memory B cells, T helper cells, cytotoxic T cells) which, when reactivated, can produce antibodies and kill infected cells, even as antibody titers fade.
18. Recognize mRNA Vaccine Potency Signs
Be aware that common lymph node enlargement (ipsilateral lymphadenopathy) after mRNA vaccination is a sign of a powerful immune response, similar to other potent immunogens like the smallpox vaccine.
19. Stay Informed on Variant Protection
Keep updated on how well current immunity (from natural infection or vaccination) protects against new SARS-CoV-2 variants, noting that while some variants like B117 are well-covered, others like South African and Brazilian strains require close monitoring for severe disease escape.
5 Key Quotes
If you want a research career that lasts for the rest of your life, study influenza.
Paul Offit (quoting his lab head)
If people don't use reason or logic to come to a specific conclusion, reason and logic are not going to talk them out of it.
Paul Offit (quoting Neil deGrasse Tyson)
We are roughly a 4% of the world's population and 20% of the world's deaths when we have a technologically and economically advanced society. So, there's really no excuse for doing it as badly as we did it.
Paul Offit
What about me? I depend on you to protect me. Don't I count?
Paul Offit (quoting a child with leukemia)
This is a virus that has an incubation period of around six days... The longer incubation period diseases are better in the sense that you really can induce sterilizing immunity, and therefore you really can eliminate those viruses.
Paul Offit